Summary

Electro-medical And Electrotherapeutic Apparatus Market Growth & Trends

The global electro-medical and electrotherapeutic apparatus market size is anticipated to reach USD 95.5 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to grow at a CAGR of 6.4% from 2025 to 2030. Key factors driving market growth include the increasing geriatric population, advancements in technology, rising awareness among patients about diagnostic and treatment options, and the growing prevalence of various chronic disorders. For instance, the International Agency for Research on Cancer reported approximately 19,976,499 new cancer cases and 9,743,832 cancer-related deaths worldwide in 2022.

The growing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions necessitates the need for effective diagnostic and treatment solutions. Electro-medical and electrotherapeutic apparatus play a crucial role in addressing this need by offering efficient and advanced devices that support accurate diagnoses, monitor patient conditions, and deliver therapeutic treatments. These devices are essential in improving patient outcomes and managing chronic conditions more effectively. Advancements in technology is further expected to contribute to overall market growth. For instance, in April 2024, Soterix Medical Inc., a global leader in non-invasive brain stimulation and complementary monitoring technologies, announced the launch of the MxN-GO EEG. This innovative system combines High-Definition transcranial Electrical Stimulation (HD-tES) with EEG, featuring a unique untethered design.

Strategic initiatives by key market players, such as mergers and acquisitions, product launches, regulatory approvals, partnerships, collaborations, research and development (R&D) efforts, and expansion, are essential in driving the growth of the market. For example, in July 2024, Philips, a global leader in health technology, announced a partnership with Star Imaging in Pune to establish a first-of-its-kind MRI Training School in India. This institution will offer internationally recognized training on MRI technologies across 17 sub-specialties.

Electro-Medical And Electrotherapeutic Apparatus Market Report Highlights

• In 2024, the diagnostic segment dominated the product segment by capturing a share of 37.9%.

• The therapeutic equipment segment is anticipated to grow at the fastest CAGR during the forecast period.

• Cardiology segment held the largest market share in the application segment by capturing a revenue share of 26.9% in 2024.

• The neurology segment is expected to grow at the fastest rate during the forecast period.

• Among end use, hospitals held a majority share of the market of 46.5% in 2024.

• The ambulatory surgical centers segment is expected to grow at the fastest rate over the forecast period.

• North America dominated the market with a share of 47.0% in 2024.

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Electro-medical and Electrotherapeutic Apparatus Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of chronic disorders
3.2.1.2. Growing awareness among public regarding advanced diagnostic and treatment options
3.2.1.3. Rising geriatric population
3.2.1.4. Advancements in technology
3.2.2. Market restraint analysis
3.2.2.1. High cost of devices
3.2.2.2. Complex regulatory environment
3.3. Electro-medical and Electrotherapeutic Apparatus Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Electro-medical and Electrotherapeutic Apparatus Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Electro-medical and Electrotherapeutic Apparatus Product Market Movement Analysis
4.3. Global Electro-medical and Electrotherapeutic Apparatus Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Diagnostic Equipment
4.4.1. Diagnostic equipment market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Therapeutic Equipment
4.5.1. Therapeutic equipment market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Surgical Devices
4.6.1. Surgical devices market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Patient Assistive Devices
4.7.1. Patient assistive devices market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Others
4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Electro-medical and Electrotherapeutic Apparatus Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Electro-medical and Electrotherapeutic Apparatus Application Market Movement Analysis
5.3. Global Electro-medical and Electrotherapeutic Apparatus Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Cardiology
5.4.1. Cardiology market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Neurology
5.5.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Oncology
5.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Orthopedics
5.7.1. Orthopedics market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Gynecology
5.8.1. Gynecology market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Urology
5.9.1. Urology market estimates and forecasts 2018 to 2030 (USD Million)
5.10. Others
5.10.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Electro-medical and Electrotherapeutic Apparatus Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Electro-medical and Electrotherapeutic Apparatus End Use Market Movement Analysis
6.3. Global Electro-medical and Electrotherapeutic Apparatus Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Ambulatory Surgical Centers
6.5.1. Ambulatory surgical centers market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Diagnostic Centers
6.6.1. Diagnostic centers market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Others
6.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Electro-medical and Electrotherapeutic Apparatus Market: Regional Estimates & Trend Analysis By Product, Application, End Use
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Competitive scenario
7.5.1.3. Regulatory framework
7.5.1.4. Reimbursement structure
7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Reimbursement structure
7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. Reimbursement structure
7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Competitive scenario
7.6.1.3. Regulatory framework
7.6.1.4. Reimbursement structure
7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement structure
7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement structure
7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Regulatory framework
7.6.4.4. Reimbursement structure
7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Regulatory framework
7.6.5.4. Reimbursement structure
7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Regulatory framework
7.6.6.4. Reimbursement structure
7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Regulatory framework
7.6.7.4. Reimbursement structure
7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Competitive scenario
7.6.8.3. Regulatory framework
7.6.8.4. Reimbursement structure
7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Competitive scenario
7.7.1.3. Regulatory framework
7.7.1.4. Reimbursement structure
7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement structure
7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement structure
7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement structure
7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement structure
7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Competitive scenario
7.7.6.3. Regulatory framework
7.7.6.4. Reimbursement structure
7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Competitive scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement structure
7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Argentina
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement structure
7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Competitive scenario
7.9.1.3. Regulatory framework
7.9.1.4. Reimbursement structure
7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Competitive scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement structure
7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Competitive scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement structure
7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Competitive scenario
7.9.4.3. Regulatory framework
7.9.4.4. Reimbursement structure
7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key company market share analysis, 2024
8.4. Company Position Analysis
8.5. Company Categorization (Emerging Players, Innovators and Leaders
8.6. Company Profiles
8.6.1. GE HealthCare
8.6.1.1. Company overview
8.6.1.2. Financial performance
8.6.1.3. Product benchmarking
8.6.1.4. Strategic initiatives
8.6.2. Koninklijke Philips N.V.
8.6.2.1. Company overview
8.6.2.2. Financial performance
8.6.2.3. Product benchmarking
8.6.2.4. Strategic initiatives
8.6.3. Siemens Healthineers AG
8.6.3.1. Company overview
8.6.3.2. Financial performance
8.6.3.3. Product benchmarking
8.6.3.4. Strategic initiatives
8.6.4. Medtronic
8.6.4.1. Company overview
8.6.4.2. Financial performance
8.6.4.3. Product benchmarking
8.6.4.4. Strategic initiatives
8.6.5. Abbott
8.6.5.1. Company overview
8.6.5.2. Financial performance
8.6.5.3. Product benchmarking
8.6.5.4. Strategic initiatives
8.6.6. Boston Scientific Corporation
8.6.6.1. Company overview
8.6.6.2. Financial performance
8.6.6.3. Product benchmarking
8.6.6.4. Strategic initiatives
8.6.7. Fujifilm Holdings Corporation
8.6.7.1. Company overview
8.6.7.2. Financial performance
8.6.7.3. Product benchmarking
8.6.7.4. Strategic initiatives
8.6.8. Zimmer Biomet
8.6.8.1. Company overview
8.6.8.2. Financial performance
8.6.8.3. Product benchmarking
8.6.8.4. Strategic initiatives
8.6.9. Nihon Kohden Corporation
8.6.9.1. Company overview
8.6.9.2. Financial performance
8.6.9.3. Product benchmarking
8.6.9.4. Strategic initiatives
8.6.10. OMRON Healthcare, Inc.
8.6.10.1. Company overview
8.6.10.2. Financial performance
8.6.10.3. Product benchmarking
8.6.10.4. Strategic initiatives
8.6.11. Invacare Corporation
8.6.11.1. Company overview
8.6.11.2. Financial performance
8.6.11.3. Product benchmarking
8.6.11.4. Strategic initiatives